| Dr Eric Allen Copeland, PSYD | |
|
2702 Cunningham Ave Ste A, Joplin, MO 64804-1593 | |
| (417) 782-1910 | |
| (417) 782-1844 |
| Full Name | Dr Eric Allen Copeland |
|---|---|
| Gender | Male |
| Speciality | Clinical Psychologist |
| Experience | 13 Years |
| Location | 2702 Cunningham Ave Ste A, Joplin, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528349792 | NPI | - | NPPES |
| 201087640A | Medicaid | KS | |
| 1528349792 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 2011028411 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ozark Center | 4789588088 | 42 |
News Archive
Podoplanin-positive cancer-associated fibroblasts predict recurrence in stage I lung adenocarcinoma, which could help identify patients suited for adjuvant chemotherapy, research shows.
ISTA Pharmaceuticals, Inc., today announced it has initiated a Phase 1/2 clinical study of bepotastine besilate nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis, the inflammation of the nasal passages caused by allergies. The randomized, placebo-controlled, parallel-group study will evaluate the safety and efficacy of three concentrations of bepotastine besilate, dosed twice daily, in an Environmental Exposure Chamber model of allergic rhinitis caused by natural exposure to seasonal allergens.
The current study suggests that deferring the second vaccination of individuals with prior infection may be a cost-effective strategy.
BioVision, the World Life Sciences Forum, will take place at the Lyon Convention Centre from March 27 to 29, 2011. During 3 days, BioVision will be the place for discussions and debates on the major life science issues with over 180 internationally renowned speakers including scientists, businesspeople and representatives of civil society and non-governmental organisations.
Light therapy decreased depressive symptoms and normalized circadian rhythms among cancer survivors, according to new research from the Icahn School of Medicine at Mount Sinai presented today at the American Psychosomatic Society in Denver, CO.
› Verified 7 days ago
| Entity Name | Ozark Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790796878 PECOS PAC ID: 4789588088 Enrollment ID: O20050223000110 |
News Archive
Podoplanin-positive cancer-associated fibroblasts predict recurrence in stage I lung adenocarcinoma, which could help identify patients suited for adjuvant chemotherapy, research shows.
ISTA Pharmaceuticals, Inc., today announced it has initiated a Phase 1/2 clinical study of bepotastine besilate nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis, the inflammation of the nasal passages caused by allergies. The randomized, placebo-controlled, parallel-group study will evaluate the safety and efficacy of three concentrations of bepotastine besilate, dosed twice daily, in an Environmental Exposure Chamber model of allergic rhinitis caused by natural exposure to seasonal allergens.
The current study suggests that deferring the second vaccination of individuals with prior infection may be a cost-effective strategy.
BioVision, the World Life Sciences Forum, will take place at the Lyon Convention Centre from March 27 to 29, 2011. During 3 days, BioVision will be the place for discussions and debates on the major life science issues with over 180 internationally renowned speakers including scientists, businesspeople and representatives of civil society and non-governmental organisations.
Light therapy decreased depressive symptoms and normalized circadian rhythms among cancer survivors, according to new research from the Icahn School of Medicine at Mount Sinai presented today at the American Psychosomatic Society in Denver, CO.
› Verified 7 days ago
| Entity Name | Behavior Management P.c. Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669481495 PECOS PAC ID: 4688610603 Enrollment ID: O20050630000016 |
News Archive
Podoplanin-positive cancer-associated fibroblasts predict recurrence in stage I lung adenocarcinoma, which could help identify patients suited for adjuvant chemotherapy, research shows.
ISTA Pharmaceuticals, Inc., today announced it has initiated a Phase 1/2 clinical study of bepotastine besilate nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis, the inflammation of the nasal passages caused by allergies. The randomized, placebo-controlled, parallel-group study will evaluate the safety and efficacy of three concentrations of bepotastine besilate, dosed twice daily, in an Environmental Exposure Chamber model of allergic rhinitis caused by natural exposure to seasonal allergens.
The current study suggests that deferring the second vaccination of individuals with prior infection may be a cost-effective strategy.
BioVision, the World Life Sciences Forum, will take place at the Lyon Convention Centre from March 27 to 29, 2011. During 3 days, BioVision will be the place for discussions and debates on the major life science issues with over 180 internationally renowned speakers including scientists, businesspeople and representatives of civil society and non-governmental organisations.
Light therapy decreased depressive symptoms and normalized circadian rhythms among cancer survivors, according to new research from the Icahn School of Medicine at Mount Sinai presented today at the American Psychosomatic Society in Denver, CO.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eric Allen Copeland, PSYD 2702 Cunningham Ave Ste A, Joplin, MO 64804-1593 Ph: (417) 782-1910 | Dr Eric Allen Copeland, PSYD 2702 Cunningham Ave Ste A, Joplin, MO 64804-1593 Ph: (417) 782-1910 |
News Archive
Podoplanin-positive cancer-associated fibroblasts predict recurrence in stage I lung adenocarcinoma, which could help identify patients suited for adjuvant chemotherapy, research shows.
ISTA Pharmaceuticals, Inc., today announced it has initiated a Phase 1/2 clinical study of bepotastine besilate nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis, the inflammation of the nasal passages caused by allergies. The randomized, placebo-controlled, parallel-group study will evaluate the safety and efficacy of three concentrations of bepotastine besilate, dosed twice daily, in an Environmental Exposure Chamber model of allergic rhinitis caused by natural exposure to seasonal allergens.
The current study suggests that deferring the second vaccination of individuals with prior infection may be a cost-effective strategy.
BioVision, the World Life Sciences Forum, will take place at the Lyon Convention Centre from March 27 to 29, 2011. During 3 days, BioVision will be the place for discussions and debates on the major life science issues with over 180 internationally renowned speakers including scientists, businesspeople and representatives of civil society and non-governmental organisations.
Light therapy decreased depressive symptoms and normalized circadian rhythms among cancer survivors, according to new research from the Icahn School of Medicine at Mount Sinai presented today at the American Psychosomatic Society in Denver, CO.
› Verified 7 days ago
Dr. Douglas A Brooks, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2702 Cunningham Ave, Ste A, Joplin, MO 64804 Phone: 417-782-1910 Fax: 417-782-1844 | |
Alan Melot, LMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3901 E 32nd St, Joplin, MO 64804 Phone: 417-347-7567 | |
Sooin Lee, Psychologist Medicare: Accepting Medicare Assignments Practice Location: 530 E 34th St, Joplin, MO 64804 Phone: 417-347-7600 Fax: 417-347-0293 | |
Mrs. Vicky Lynn Mieseler, M.S. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2808 S Picher Ave, Joplin, MO 64804 Phone: 417-347-7700 Fax: 417-347-7729 | |
John R Graue Ii, M.S. AND TH.D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1505 E 20th St, Joplin, MO 64804 Phone: 417-627-9601 Fax: 417-627-9032 | |
Blake Webster, Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1230 N Duquesne Rd, Joplin, MO 64801 Phone: 417-782-1443 Fax: 417-782-3240 | |
Mr. Wess Allen Baugh, M.S. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1230 N. Duquesne Rd, College Skyline Center, Joplin, MO 64801 Phone: 471-782-1443 Fax: 417-782-3240 |